Pharmacogenetics Leadership Canada’s most comprehensive pharmacogenetics test with a CLIA-accredited lab and Health Canada license positions Inagene as a trusted partner for medication optimization programs in clinics, hospitals, and telehealth. This enables enterprise sales to health systems and payer programs seeking pharmacogenetic solutions, with opportunities to offer white-label or integration services with existing patient care workflows.

Education Channel Past collaboration with Ontario Pharmacists Association to educate pharmacy professionals shows a ready-to-scale channel for clinician adoption. Expand national training partnerships with pharmacy chains, professional bodies, and continuing education platforms to drive demand, plus bundled test kits and volume pricing for enterprise customers.

Cardio Expansion Recent Cardiovascular Health Test launch expands addressable market into cardiology and primary care for cardiovascular medication optimization. Use cross-sell from existing pharmacogenetic customers to clinics and hospitals; pursue evidence generation and payer discussions to support reimbursement and clinical adoption.

Strategic Partnerships History of partnerships with Granville Biomedical and other suppliers demonstrates ability to source local medical-grade components and to co-develop logistics. This supports expansion of kit manufacturing, private-label opportunities for clinics, and broader distribution through health-system-facing channels.

Growth Traction Revenue range and lean team create a high-potential, scalable sales opportunity: target enterprise-level health systems, insurers, and pharmaceutical partners with pricing models tied to outcomes and integration with electronic health records. Build channel partnerships and invest in sales enablement to accelerate growth.